publication venue for
- On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.. 29. 2020
- Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study.. 28. 2019
- Prognostic impact of increased pulse pressure/stroke index in a registry of hypertensive patients: the Campania Salute Network.. 28. 2019
- Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study.. 28. 2019
- Obituary.. 26. 2017
- Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR.. 26. 2017
- Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study.. 26. 2016
- Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study.. 26. 2016
- Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).. 23. 2014
- Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment.. 23. 2013
- The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium.. 21. 2012
- Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study.. 21. 2011
- The prevalence and outcome of hypertension in patients with acute coronary syndrome in six Middle-Eastern countries.. 20. 2010
- In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.. 19. 2010
- Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.. 19. 2010
- Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.. 18. 2009
- Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).. 18. 2009
- Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.. 15. 2006
- Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy).. 15. 2006
- Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.. 14. 2005
- Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.. 13. 2004
- The effect of hypertension as a predictor of risk for congestive heart failure patients over a 10-year period in a newly developed country.. 13. 2004
- Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study.. 10. 2001
- Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects.. 9. 2000
- Glycogen synthase polymorphism, insulin resistance and hypertension.. 5. 1996
- Relationship of diastolic function to new or persistent electrocardiographic left ventricular hypertrophy. 2016
- Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future? 2007